Milacemide HCl is a MAO-B inhibitor and glycine prodrug. It is currently being studied as a treatment for the symptoms of Alzheimer's disease. References: Liljequist R. Glycine modulates N-methyl-D-aspartic acid induced learning facilitation in rats. Amino Acids. 1996 Dec;10(4):345-58. doi: 10.1007/BF00805862. PubMed PMID: 24178595.

纯度：≥98%

CAS：76990-85-7